<DOC>
	<DOCNO>NCT01147601</DOCNO>
	<brief_summary>The purpose study learn new potential use topical timolol 0.5 % aqueous solution may help treat small uncomplicated infantile hemangioma . This study would examine whether topical timolol could potential therapy .</brief_summary>
	<brief_title>Topical Timolol 0.5 % Solution Proliferating Infantile Hemangiomas</brief_title>
	<detailed_description>At first visit , subject fill questionnaire asks child 's history hemangioma . Photographs measurement take subsequent visit . At first visit , subject physical exam , include vital sign , height weight . An EKG also do . Study drug dispense instruction give . Half subject receive placebo . This blind randomize study . Follow-up visit weekly first two week ( three visit total include first visit ) , monthly study . Photographs measurement take visit . Subjects ask evaluate size color hemangioma first photograph fill form regard change behavior ask side effect .</detailed_description>
	<mesh_term>Hemangioma</mesh_term>
	<mesh_term>Hemangioma , Capillary</mesh_term>
	<mesh_term>Port-Wine Stain</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<criteria>Infants 1 month 8 month age infantile hemangioma ( IH ) 3 cm less scalp , trunk , extremity . 1 . Subjects facial , genital , perianal , hand , finger , foot , toe IH 2 . Subjects PHACES syndrome ( prove ) suspect PHACES ( plaquelike hemangioma face await image ) . 3 . Subjects IH measure 3cm size ulcerated . 4 . Children history hypersensitivity beta blocker . 5 . Children personal history asthma . 6 . Children known renal impairment . 7 . Children known cardiac condition may predispose heart block 8 . Personal history hypoglycemia 9 . Children medication may interact beta blocker</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>8 Months</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>topical 0.5 % Timolol</keyword>
	<keyword>infantile hemangioma ( IH )</keyword>
</DOC>